Intuitive Surgical, Inc. (NASDAQ:ISRG) is Unio Capital LLC’s 7th Largest Position

Unio Capital LLC cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.6% during the fourth quarter, HoldingsChannel reports. The fund owned 29,234 shares of the medical equipment provider’s stock after selling 766 shares during the period. Intuitive Surgical comprises 5.5% of Unio Capital LLC’s holdings, making the stock its 7th biggest position. Unio Capital LLC’s holdings in Intuitive Surgical were worth $15,259,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Norges Bank acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth about $2,401,493,000. Proficio Capital Partners LLC boosted its holdings in Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after purchasing an additional 948,902 shares during the period. Capital Research Global Investors increased its holdings in Intuitive Surgical by 25.5% during the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider’s stock worth $1,764,904,000 after purchasing an additional 687,906 shares during the period. Raymond James Financial Inc. acquired a new stake in Intuitive Surgical in the 4th quarter valued at about $313,769,000. Finally, Northern Trust Corp grew its position in shares of Intuitive Surgical by 15.8% during the fourth quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider’s stock worth $1,889,126,000 after buying an additional 494,496 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Shares of ISRG opened at $561.63 on Tuesday. The stock has a market cap of $201.30 billion, a PE ratio of 87.62, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 12 month low of $395.60 and a 12 month high of $616.00. The stock’s 50-day moving average is $506.50 and its two-hundred day moving average is $537.23.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter in the previous year, the firm posted $1.50 EPS. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

ISRG has been the subject of a number of recent research reports. UBS Group lifted their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Jefferies Financial Group raised their price target on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. JPMorgan Chase & Co. raised their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Citigroup upped their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. Finally, Bernstein Bank boosted their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $598.95.

Insider Buying and Selling

In other news, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. The trade was a 68.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Jamie Samath sold 188 shares of the business’s stock in a transaction on Friday, February 28th. The stock was sold at an average price of $566.94, for a total value of $106,584.72. Following the completion of the sale, the chief financial officer now directly owns 7,162 shares in the company, valued at $4,060,424.28. This represents a 2.56% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 32,700 shares of company stock worth $16,865,621 over the last quarter. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.